Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 436

1.

Development of New Biologics through Creation of a Functional Cytokine Mutant.

Kamada H.

Yakugaku Zasshi. 2015;135(7):843-9. doi: 10.1248/yakushi.15-00007-1.

2.

A target-controlled infusion system with bispectral index monitoring of propofol sedation during endoscopic submucosal dissection.

Imagawa A, Hata H, Nakatsu M, Matsumi A, Ueta E, Suto K, Terasawa H, Sakae H, Takeuchi K, Fujihara M, Endo H, Yasuhara H, Ishihara S, Kanzaki H, Jinno H, Kamada H, Kaji E, Moriya A, Ando M.

Endosc Int Open. 2015 Feb;3(1):E2-6. doi: 10.1055/s-0034-1377519. Epub 2014 Nov 17.

3.

Cutaneous exposure to agglomerates of silica nanoparticles and allergen results in IgE-biased immune response and increased sensitivity to anaphylaxis in mice.

Hirai T, Yoshioka Y, Takahashi H, Ichihashi K, Udaka A, Mori T, Nishijima N, Yoshida T, Nagano K, Kamada H, Tsunoda S, Takagi T, Ishii KJ, Nabeshi H, Yoshikawa T, Higashisaka K, Tsutsumi Y.

Part Fibre Toxicol. 2015 Jun 26;12(1):16. doi: 10.1186/s12989-015-0095-3.

4.

Evaluation of silica nanoparticle binding to major human blood proteins.

Hata K, Higashisaka K, Nagano K, Mukai Y, Kamada H, Tsunoda S, Yoshioka Y, Tsutsumi Y.

Nanoscale Res Lett. 2014 Dec;9(1):2493. doi: 10.1186/1556-276X-9-668. Epub 2014 Dec 11.

5.

Protein corona changes mediated by surface modification of amorphous silica nanoparticles suppress acute toxicity and activation of intrinsic coagulation cascade in mice.

Yoshida T, Yoshioka Y, Morishita Y, Aoyama M, Tochigi S, Hirai T, Tanaka K, Nagano K, Kamada H, Tsunoda S, Nabeshi H, Yoshikawa T, Higashisaka K, Tsutsumi Y.

Nanotechnology. 2015 Jun 19;26(24):245101. doi: 10.1088/0957-4484/26/24/245101. Epub 2015 May 26.

PMID:
26011124
6.

Identification and evaluation of metastasis-related proteins, oxysterol binding protein-like 5 and calumenin, in lung tumors.

Nagano K, Imai S, Zhao X, Yamashita T, Yoshioka Y, Abe Y, Mukai Y, Kamada H, Nakagawa S, Tsutsumi Y, Tsunoda S.

Int J Oncol. 2015 Jul;47(1):195-203. doi: 10.3892/ijo.2015.3000. Epub 2015 May 11.

PMID:
25963840
7.

Adult classical glioblastoma with a BRAF V600E mutation.

Takahashi Y, Akahane T, Sawada T, Ikeda H, Tempaku A, Yamauchi S, Nishihara H, Tanaka S, Nitta K, Ide W, Hashimoto I, Kamada H.

World J Surg Oncol. 2015 Mar 11;13:100. doi: 10.1186/s12957-015-0521-x.

8.

Oncogenic osteomalacia caused by an occult paranasal sinus tumor.

Okamiya T, Takahashi K, Kamada H, Hirato J, Motoi T, Fukumoto S, Chikamatsu K.

Auris Nasus Larynx. 2015 Apr;42(2):167-9. doi: 10.1016/j.anl.2014.10.001. Epub 2015 Feb 11.

PMID:
25682388
9.

Evaluation of HNA-expressing cell line-based antigen capture systems and a solid-phase system for detecting HNA-1a antibodies.

Amakishi E, Irie Y, Nishizawa K, Kamada H, Nakajima F, Matsuyama N, Ishii H, Matsukura H, Yasui K, Hirayama F.

Int J Hematol. 2015 Apr;101(4):386-91. doi: 10.1007/s12185-015-1751-y. Epub 2015 Feb 3.

PMID:
25644150
10.

Factors influencing lymph node metastasis in patients with ampullary adenocarcinoma.

Okano K, Asano E, Kushida Y, Kamada H, Mori H, Suzuki Y.

Dig Surg. 2014;31(6):459-67. doi: 10.1159/000370251. Epub 2015 Jan 21.

PMID:
25613423
11.

Aminopeptidase P3, a new member of the TNF-TNFR2 signaling complex, induces phosphorylation of JNK1 and JNK2.

Inoue M, Kamada H, Abe Y, Higashisaka K, Nagano K, Mukai Y, Yoshioka Y, Tsutsumi Y, Tsunoda S.

J Cell Sci. 2015 Feb 15;128(4):656-69. doi: 10.1242/jcs.149385. Epub 2015 Jan 20.

PMID:
25609706
12.

Treatment outcomes of chemotherapy between unresectable and recurrent biliary tract cancer.

Sasaki T, Isayama H, Nakai Y, Ito Y, Yasuda I, Toda N, Yagioka H, Matsubara S, Hanada K, Maguchi H, Kamada H, Hasebe O, Mukai T, Okabe Y, Maetani I, Koike K.

World J Gastroenterol. 2014 Dec 28;20(48):18452-7. doi: 10.3748/wjg.v20.i48.18452.

13.

Generation and characterization of a bispecific diabody targeting both EPH receptor A10 and CD3.

Kamada H, Taki S, Nagano K, Inoue M, Ando D, Mukai Y, Higashisaka K, Yoshioka Y, Tsutsumi Y, Tsunoda S.

Biochem Biophys Res Commun. 2015 Jan 24;456(4):908-12. doi: 10.1016/j.bbrc.2014.12.030. Epub 2014 Dec 17.

PMID:
25528586
14.

Size and surface modification of amorphous silica particles determine their effects on the activity of human CYP3A4 in vitro.

Imai S, Yoshioka Y, Morishita Y, Yoshida T, Uji M, Nagano K, Mukai Y, Kamada H, Tsunoda S, Higashisaka K, Tsutsumi Y.

Nanoscale Res Lett. 2014 Dec 2;9(1):651. doi: 10.1186/1556-276X-9-651. eCollection 2014.

15.

Analysis of the amount of tissue sample necessary for mitotic count and Ki-67 index in gastrointestinal stromal tumor sampling.

Kobara H, Mori H, Rafiq K, Fujihara S, Nishiyama N, Chiyo T, Matsunaga T, Ayaki M, Yachida T, Kato K, Kamada H, Fujita K, Morishita A, Oryu M, Tsutsui K, Iwama H, Kushida Y, Haba R, Masaki T.

Oncol Rep. 2015 Jan;33(1):215-22. doi: 10.3892/or.2014.3608. Epub 2014 Nov 14.

PMID:
25405369
16.

Intestinal absorption and biological effects of orally administered amorphous silica particles.

Yoshida T, Yoshioka Y, Takahashi H, Misato K, Mori T, Hirai T, Nagano K, Abe Y, Mukai Y, Kamada H, Tsunoda S, Nabeshi H, Yoshikawa T, Higashisaka K, Tsutsumi Y.

Nanoscale Res Lett. 2014 Sep 26;9(1):532. doi: 10.1186/1556-276X-9-532. eCollection 2014.

17.

Usefulness of 11C-methionine positron emission tomography for detecting intracranial ameloblastic carcinoma: A case report.

Tempaku A, Takahashi Y, Ikeda H, Yamauchi S, Gotoh T, Bandoh N, Makino S, Shimada T, Kamada H.

Oncol Lett. 2014 Oct;8(4):1509-1512. Epub 2014 Jul 15.

18.

Clinical characteristics and pathogenesis of cerebellar glioblastoma.

Takahashi Y, Makino K, Nakamura H, Hide T, Yano S, Kamada H, Kuratsu J.

Mol Med Rep. 2014 Nov;10(5):2383-8. doi: 10.3892/mmr.2014.2549. Epub 2014 Sep 9.

PMID:
25199771
19.

Evaluation of gastric submucosal tumors using endoscopically visualized features with submucosal endoscopy.

Kobara H, Mori H, Rafiq K, Matsunaga T, Fujihara S, Nishiyama N, Ayaki M, Yachida T, Tani J, Miyoshi H, Kato K, Kamada H, Yoneyama H, Morishita A, Tsutsui K, Iwama H, Haba R, Masaki T.

Oncol Lett. 2014 Jul;8(1):161-168. Epub 2014 May 8.

20.

Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers.

Nagano K, Maeda Y, Kanasaki S, Watanabe T, Yamashita T, Inoue M, Higashisaka K, Yoshioka Y, Abe Y, Mukai Y, Kamada H, Tsutsumi Y, Tsunoda S.

J Control Release. 2014 Sep 10;189:72-9. doi: 10.1016/j.jconrel.2014.06.010. Epub 2014 Jun 16.

PMID:
24946238
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk